Repose

The compounds already known. The evidence still to come.

A Synapse Spark Foundation venture

Pharma Licensing Portal

Path B — Licensing

Email Password

Projects—

Predictions—

Scoring runs remaining—

Your Projects

Top Scored Compounds

Compound	Target class	Score	MPO	Safety	Matrix

Open a Licensing Inquiry

Compound ID Partner Proposed upfront (USD, optional)

Preclinical scoring for research and partnership evaluation only. Not a claim of efficacy or safety in any indication. The full FDA clinical pathway applies to every asset.

A Synapse Spark Foundation venture · Revenue funds neurodevelopment research grants.